HCV infection is related to hepatic disease and mixed cryoglobulinaemia (MC). Renal involvement is reported in one third of cryoglobulinaemic patients. The combination of HCV-related MC with renal involvement has been associated with poor survival and identified as “Hepatitis C Virus Risk Syndrome (HCV-RS)”. Here we describe antiviral treatment and management of side effects (anaemia and neutropenia) with RHuEpo and GCSF in a rare case of HCV-RS.
|Translated title of the contribution||Recombinant human erythropoietin (RHuEpo) and granular colony stimulating factor (G-CSF) in hepatitis c virus (HCV) related to mixed cryoglobulinaemia associated to membranoproliferative glomerulonephritis type i: A case report description|
|Number of pages||5|
|Journal||Infezioni in Medicina|
|Publication status||Published - Dec 1 2014|
ASJC Scopus subject areas
- Microbiology (medical)
- Infectious Diseases